{
  "variants": [
    {
      "variant": {
        "gene": "UCH-L1",
        "position": 30,
        "reference": "D",
        "alternate": "K",
        "chromosome": null,
        "functional_consequence": "Decreased secretion due to loss of ubiquitin binding activity."
      },
      "functional_evidence": {
        "evidence": "Secretion of D30K variant is decreased compared to wild-type.",
        "steps": {
          "step1": {
            "question": "Is the variant associated with a disease-relevant functional consequence?",
            "answer": "Yes",
            "reasoning": "The variant (D30K) causes decreased secretion, a disease-relevant phenotype in Parkinson's disease."
          },
          "step2": {
            "question": "Is the assay relevant to the disease mechanism?",
            "answer": "Yes",
            "reasoning": "Secretion is a key functional process disrupted in Parkinson's disease."
          },
          "step3": {
            "question": "Is the assay validated and reproducible?",
            "answer": "No",
            "reasoning": "The abstract does not mention replication or validation details."
          },
          "step4": {
            "question": "Does the functional effect support pathogenicity?",
            "answer": "Yes",
            "reasoning": "The variant's functional defect aligns with the disease mechanism."
          }
        },
        "classification": {
          "category": "PS3",
          "level": "Supporting",
          "reasoning": "The functional evidence supports pathogenicity but lacks full validation."
        }
      }
    },
    {
      "variant": {
        "gene": "UCH-L1",
        "position": 90,
        "reference": "C",
        "alternate": "S",
        "chromosome": null,
        "functional_consequence": "No change in secretion despite loss of hydrolase activity."
      },
      "functional_evidence": {
        "evidence": "Secretion of C90S variant is not decreased compared to wild-type.",
        "steps": {
          "step1": {
            "question": "Is the variant associated with a disease-relevant functional consequence?",
            "answer": "No",
            "reasoning": "The variant (C90S) does not affect secretion, a disease-relevant phenotype."
          },
          "step2": {
            "question": "Is the assay relevant to the disease mechanism?",
            "answer": "Yes",
            "reasoning": "Secretion is a key functional process in Parkinson's disease."
          },
          "step3": {
            "question": "Is the assay validated and reproducible?",
            "answer": "No",
            "reasoning": "The abstract does not mention replication or validation details."
          },
          "step4": {
            "question": "Does the functional effect support benignity?",
            "answer": "Yes",
            "reasoning": "The variant's lack of functional defect aligns with a benign classification."
          }
        },
        "classification": {
          "category": "BS3",
          "level": "Supporting",
          "reasoning": "The functional evidence supports benignity but lacks full validation."
        }
      }
    },
    {
      "variant": {
        "gene": "UCH-L1",
        "position": 93,
        "reference": "I",
        "alternate": "M",
        "chromosome": null,
        "functional_consequence": "Decreased secretion in a Parkinson's disease-associated mutation."
      },
      "functional_evidence": {
        "evidence": "Secretion of I93M variant is decreased compared to wild-type.",
        "steps": {
          "step1": {
            "question": "Is the variant associated with a disease-relevant functional consequence?",
            "answer": "Yes",
            "reasoning": "The variant (I93M) causes decreased secretion, a disease-relevant phenotype in Parkinson's disease."
          },
          "step2": {
            "question": "Is the assay relevant to the disease mechanism?",
            "answer": "Yes",
            "reasoning": "Secretion is a key functional process disrupted in Parkinson's disease."
          },
          "step3": {
            "question": "Is the assay validated and reproducible?",
            "answer": "No",
            "reasoning": "The abstract does not mention replication or validation details."
          },
          "step4": {
            "question": "Does the functional effect support pathogenicity?",
            "answer": "Yes",
            "reasoning": "The variant's functional defect aligns with the disease mechanism."
          }
        },
        "classification": {
          "category": "PS3",
          "level": "Supporting",
          "reasoning": "The functional evidence supports pathogenicity but lacks full validation."
        }
      }
    }
  ]
}